Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Mar;13(1):5-6.
doi: 10.1159/000486927. Epub 2018 Feb 13.

Immunotherapy of Breast Cancer

Affiliations
Editorial

Immunotherapy of Breast Cancer

Barbara Seliger. Breast Care (Basel). 2018 Mar.
No abstract available

PubMed Disclaimer

References

    1. Würfel F, Erber R, Huebner H, Hein A, Lux MP, Jud S, Kremer A, Kranich H, Mackensen A, Häberle L, Hack CC, Rauh C, Wunderle M, Gaß P, Rabizadeh S, Brandl A-L, Langemann H, Volz B, Nabieva N, Schulz-Wendtland R, Dudziak D, Beckmann MW, Hartmann A, Fasching PA, Rübner M. TILGen: a program to investigate immune targets in breast cancer patients - first results on the influence of tumor-infiltrating lymphocytes. Breast Care. 2018;13 DOI: 10.1159/000486949. - PMC - PubMed
    1. Seliger B, Steven A. The role of immune escape and immune cell infiltration in breast cancer. Breast Care. 2018;13 DOI: 10.1159/000486585. - PMC - PubMed
    1. Schütz F, Marmé F, Domschke C, Sohn C, von Au A. Immunooncology in breast cancer: active and passive vaccination strategies. Breast Care. 2018;13 DOI: 10.1159/000486330. - PMC - PubMed
    1. Bischoff J. Checkpoint inhibitors in breast cancer - current status and future directions. Breast Care. 2018;13 DOI: 10.1159/000486706. - PMC - PubMed

Publication types

LinkOut - more resources